Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
0.7191
+0.0192 (2.74%)
At close: May 9, 2025, 4:00 PM
0.7092
-0.0099 (-1.38%)
After-hours: May 9, 2025, 4:00 PM EDT

Ironwood Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
317.68351.41442.74410.6413.75389.52
Upgrade
Revenue Growth (YoY)
-23.18%-20.63%7.83%-0.76%6.22%-9.08%
Upgrade
Cost of Revenue
9.177.556.154.9470.4191.2
Upgrade
Gross Profit
308.51343.86436.59405.66343.35298.33
Upgrade
Selling, General & Admin
130.93144.27142.11115.99111.13140
Upgrade
Research & Development
103.87103.8798.6439.33--
Upgrade
Operating Expenses
234.8248.14240.75155.32111.13140
Upgrade
Operating Income
73.7195.72195.84250.34232.22158.32
Upgrade
Interest Expense
-34.12-33.29-21.38-7.6-31.15-29.48
Upgrade
Interest & Investment Income
4.174.4718.979.50.731.5
Upgrade
Other Non Operating Income (Expenses)
0.930.89-0.230.18-1.18-6.11
Upgrade
EBT Excluding Unusual Items
44.6867.79193.2252.42200.61124.24
Upgrade
Merger & Restructuring Charges
-20.72-2.59-45.82-0.04-15.38
Upgrade
Pretax Income
23.9765.2-948.07252.42200.66108.86
Upgrade
Income Tax Expense
56.3164.3283.4977.36-327.792.69
Upgrade
Earnings From Continuing Operations
-32.340.88-1,032175.07528.45106.18
Upgrade
Net Income to Company
-32.340.88-1,032175.07528.45106.18
Upgrade
Minority Interest in Earnings
--29.32---
Upgrade
Net Income
-32.340.88-1,002175.07528.45106.18
Upgrade
Net Income to Common
-32.340.88-1,002175.07528.45106.18
Upgrade
Net Income Growth
----66.87%397.71%393.73%
Upgrade
Shares Outstanding (Basic)
160159155154162159
Upgrade
Shares Outstanding (Diluted)
160160155186164161
Upgrade
Shares Change (YoY)
2.34%2.99%-16.57%13.32%2.34%2.97%
Upgrade
EPS (Basic)
-0.200.01-6.451.133.260.67
Upgrade
EPS (Diluted)
-0.200.01-6.450.963.210.66
Upgrade
EPS Growth
----69.98%386.36%378.84%
Upgrade
Free Cash Flow
-103.41183.15273.63261.63166.99
Upgrade
Free Cash Flow Per Share
-0.651.181.471.591.04
Upgrade
Gross Margin
97.11%97.85%98.61%98.80%82.98%76.59%
Upgrade
Operating Margin
23.20%27.24%44.23%60.97%56.12%40.64%
Upgrade
Profit Margin
-10.18%0.25%-226.37%42.64%127.72%27.26%
Upgrade
Free Cash Flow Margin
-29.43%41.37%66.64%63.23%42.87%
Upgrade
EBITDA
75.7197.73197.41251.76233.74160.69
Upgrade
EBITDA Margin
23.83%27.81%44.59%61.31%56.49%41.25%
Upgrade
D&A For EBITDA
22.011.581.421.522.36
Upgrade
EBIT
73.7195.72195.84250.34232.22158.32
Upgrade
EBIT Margin
23.20%27.24%44.23%60.97%56.12%40.64%
Upgrade
Effective Tax Rate
234.95%98.65%-30.65%-2.47%
Upgrade
Revenue as Reported
351.41351.41442.74410.6413.75389.52
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q